Jeff Ubben, the CEO of activist investor ValueAct Capital, spoke briefly with Axios about his firm's acquisition of a 5% stake in private equity giant KKR & Co. Two notes:

Investment thesis: Ubben believes that KKR stock is undervalued, so either the markets begin to get it "right" or KKR management will eventually choose to convert the structure (perhaps a take-private?). Either way, ValueAct would get paid.

Differentiator: So why KKR, given that stock price undervaluing could also be an argument for buying into, say, Apollo? The answer is KKR's outsized balance sheet, which Ubben sees as a flexibility boon whereas many other managers view it as a burden. For context, S&P Capital IQ shows that KKR's total balance sheet assets were around $39 billion at the end of 2016. Blackstone was $26 billion, Carlyle was around $10 billion and Apollo was $5.6 billion.

Go deeper

Child care crisis is denting the labor market

Reproduced from Pew Research Center; Chart: Axios Visuals

New data from the Pew Research Center shows that parents are being hit especially hard by the coronavirus pandemic, and as far as job losses go, mothers and fathers are faring equally poorly.

Why it matters: Economists have been warning for months that the pandemic could do long-term damage to the economy as people remain unemployed for longer stretches of time.

Mike Allen, author of AM
2 hours ago - Politics & Policy

Trump-Biden venom on display during final debate

Photos: Brendan Smialowski/AFP via Getty Images; Jim Watson/AFP via Getty Images

Joe Biden twice referred to President Trump as "this guy," and Trump called the former vice president's family "like a vacuum cleaner" for foreign money.

Why it matters: The personal venom — during Thursday's final presidential debate, in Nashville — was a reminder that even during a more normal debate, nothing this year is normal.

Dave Lawler, author of World
3 hours ago - World

Special report: Trump's hopes of nuclear deal with Putin come down to the wire

Illustration: Lazaro Gamio/Axios

A surprise offer from Vladimir Putin has the U.S. and Russia once again circling a potential pre-election nuclear deal.

The big picture: The last treaty constraining the U.S. and Russia, New START, is due to expire on Feb. 5, 2021, two weeks after the next U.S. presidential inauguration. For the first time since the height of the Cold War, the nuclear guardrails could come off.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!